Antiviral effect of mifepristone on Pseudorabies virus and its synergistic effect with hydroquinone

LI Zitong,ZHAO Chenyao,ZHU Huixin,LAN Peiru,WANG Xianwei
DOI: https://doi.org/10.7685/jnau.202110034
2023-01-01
Abstract:[Objectives]The anti-PRV effect of the drug mifepristone and its synergistic effect with another anti-PRV drug, hydroquinone were investigated to lay the foundation for the research and clinical application of anti-PRV drugs. [Methods]The effect of mifepristone and its combination with hydroquinone on PRV replication in vitro and the stage of action that produced the effect were examined by Western blot and qPCR,and its antiviral effect and synergistic effect with hydroquinone combination were further confirmed by mouse attack protection test. [Results]The antiviral effect of mifepristone at 15 μmol·L -1 increased with increasing drug concentration and occurred at an early stage of PRV replication. The results of in vitro and in vivo tests showed that mifepristone(5 μmol·L -1 in vivo,40 mg·kg -1 in vitro)alone or in combination with hydroquinone(5 μmol·L -1 in vivo,50 mg·kg -1 in vitro)had antiviral effects and synergistic antiviral effects with hydroquinone. It also reduced the damage to the liver caused by hydroquinone. [Conclusions]Mifepristone had an antiviral effect in the early stage of virus replication, and the combination with hydroquinone had a better antiviral effect. At the same time, it could reduce the damage of hydroquinone to the liver and make up for the efficacy of mifepristone.
What problem does this paper attempt to address?